week 2 Flashcards
what determines binding?
- receptor and ligand concentration
- the likelihood of ligand to bind to receptor (affinity)
- the likelihood of ligand to activate receptor (efficacy)
What is affinity, how is it quantified?
affinity is a measure of the attraction of a ligand for a biological target. quantified by equilibrium dissociation constant, Ka. Ka = ligand concentration at which half of the receptors are occupied with drug at equilibrium. drugs with lower Ka have a higher affinity.
what are the properties of a high affinity ligand?
high affinity ligands bind to its target rapidly, bind for longer at the target, and there are many bound targets at lower concentrations.
what efficacy and how is it quantified?
efficacy is the strength of the agonst-receptor complex in evoking a response of the tissue. quantified by Emax, the maximal response/effect that a drug can produce. partal agonists have lower Emax compared to full agonists.
What is potency and how is it quantified?
the drug concentration required to elicit a given effect. quantified by EC50, the concentration that elicits a 50% response. drugs with lower EC50 have higher potency.
What is Receptor Reserve?
receptor reserve, refers to a phenomenon where not all available receptors need to be occupied by an agonist to produce Emax. This explains why some drugs can produce strong effects at lower doses.
What is desensitisation (tachyphylaxis) and diminished tolerance and what are the causes?
the effect of a drug can gradually diminish upon continuous administration either minutes or less (tachphylaxis) or hours/days/weeks (tolerance). change in receptor expression, exhastion od mediators, physiological adaption.
Define antagonist
A molecule that interferes with the interaction of an agonist and a receptor protein or a molecule that blocks the constitutive elevated basal response of a physiological system.
What are competitive antagonists (reversible)
most common type of antagonist due to high potency and selectivity. the drug binds to agonist binding site (orthosteric site), and does not activate the receptor. It prevents the agonist from binding, and dissociates and rebounds continuously.
It shifts the curve to the right, reducing the potency of the agonist. The effects of the antagonist can be overcome by increasing concentration of agonist (competing for same site).
how are reversible competitive antagonists quantified?
Kb is the equilibrium dissociation constant of competitive antagonists, a measure of affinity.
IC50 is the concentration of antagonist required to reduce a response to a fixed concentrstion of agonist by 50%.
IC50 is dependent on the concentration of agonist: more agonist requires more antagonist for the same amount of inhibition.
What are competitive antagonists (irreversible)
binds to the agonist binding site covalently (or dissociates very slowly), termed the orthosteric site, without activating the receptor. prevents agonist from binding to that site.
At high enough concentration, irreversible competitive antagonists cannot be outcompeted = insurmountable inhibition.
both potency and Emax decrease, however, it may not show reduced Emax if there are spare receptors.
What are non-competitive antagonists?
binds to an allosteric site (binds to the receptor at a different place to the agonist). upon binding, changes the conformational shape of the receptor, decreasing the affinity and efficacy of agonist to orthosteric site.
what is a chemical antagonist?
A molecule which directly binds to or destroys the ligand/agonist, preventing it from binding to it’s receptor.
What are functional (physiological) antagonists.
oppose the biological effects of an agonist by acting at a different receptor (as an agonist).
What are the major parts of the central nervous system?
- cerebrum
- diencephalon (hypothalamus, thalamus, pineal gland)
- Brainstem (midbrain, pons, medulla oblongata)
- cerebellum
- spinal cord